Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ultrasound in the Evaluation of Dactylitis and Enthesitis in Psoriatic Arthritis.

European journal of rheumatology·2024

Same author

Identifying Clinicoradiological Phenotypes in Diffuse Idiopathic Skeletal Hyperostosis: A Cross-Sectional Study.

Medicina (Kaunas, Lithuania)·2021

Same author

Clinical and genetic characteristics of ankylosing spondylitis patients with peripheral arthritis at disease onset.

Clinical and experimental rheumatology·2018

Same author

Atlantoaxial rotatory dislocation in a patient with psoriatic spondyloarthritis.

Joint bone spine·2018

Same author

Should over-treatment of axial spondyloarthritis with biologics remain a concern after the issue of the new ASAS criteria? Data from REGISPONSERBIO (Spanish Register of Biological Therapy in Spondyloarthritides).

Clinical and experimental rheumatology·2018

Same author

VARIAR Study: Assessment of short-term efficacy and safety of rituximab compared to an tumor necrosis factor alpha antagonists as second-line drug therapy in patients with rheumatoid arthritis refractory to a first tumor necrosis factor alpha antagonist.

Reumatologia clinica·2016

Same journal

Clinical validation of video DASH for upper limb disorders in rheumatic patients.

Reumatologia clinica·2026

Same journal

Coexistence of systemic lupus erythematosus and sarcoidosis: A case-based review.

Reumatologia clinica·2026

Same journal

Factors associated with the perception of body image in patients with psoriatic disease.

Reumatologia clinica·2026

Same journal

Anti-Mi-2-positive amyopathic dermatomyositis unveiled by a V-sign.

Reumatologia clinica·2026

Same journal

Antinuclear antibody detection beyond anti-dsDNA and anti-ENA: New insights from intact HEp-2 nucleus ELISA.

Reumatologia clinica·2026

Same journal

Long-term stability of autoantibody-based serological profiles in systemic lupus erythematosus.

Reumatologia clinica·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 2, 2026

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis

Published on: October 6, 2023

Diffuse idiopathic skeletal hyperostosis: Can we identify a peripheral pattern?

Teresa Clavaguera¹, Patrícia Reyner¹, Ramón Valls²

¹Unidad de Reumatología, Hospital Universitario Doctor Trueta/Santa Caterina, Gerona, España.

Reumatologia Clinica

|May 23, 2017

Summary

This summary is machine-generated.

Diffuse idiopathic skeletal hyperostosis (DISH) criteria need revision. Current criteria exclude extraspinal manifestations, hindering diagnosis in some patients with compatible hyperostotic disease.

Keywords:

Comorbidity Comorbilidad Diffuse idiopathic skeletal hyperostosis Entesis Entesopatía Enthesis Enthesopathy Hiperostosis esquelética difusa idiopática

More Related Videos

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

Related Experiment Videos

Last Updated: Mar 2, 2026

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis

Published on: October 6, 2023

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

Area of Science:

Rheumatology
Orthopedics
Radiology

Background:

Diffuse idiopathic skeletal hyperostosis (DISH) is a common skeletal disorder.
Current diagnostic criteria focus on spinal ossification, neglecting extraspinal involvement.

Observation:

Three patients presented with clinical and radiological signs of hyperostotic disease.
These patients could not be diagnosed with DISH using existing criteria due to lack of extraspinal manifestation inclusion.

Findings:

The classic DISH classification criteria are insufficient for diagnosing all patients with hyperostotic disease.
Extraspinal manifestations are crucial for a comprehensive DISH diagnosis.

Implications:

Revision of DISH diagnostic criteria is necessary to include extraspinal manifestations.
Improved diagnostic accuracy for DISH will enhance patient management and understanding of the disease spectrum.